GYRE · Gyre Therapeutics, Inc.

$6.93 -0.10 (-1.35%)

Market Cap

$778.90M

111.51M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	Filing Date	Period
8-K	2026-08-07	—
10-Q	2026-08-07	2026-06-30
8-K	2026-07-16	2026-07-10
8-K/A	2026-07-15	2026-05-04
8-K	2026-06-16	2026-06-10
8-K	2026-06-02	2026-06-01
8-K	2026-05-14	—
8-K	2026-05-12	—
10-Q	2026-05-08	2026-03-31
8-K	2026-05-07	—
8-K	2026-05-04	—
DEF 14A	2026-04-27	2026-06-10
8-K/A	2026-04-17	2026-03-02
8-K	2026-03-23	2026-03-22
10-K	2026-03-13	2025-12-31
8-K	2026-03-12	—
8-K	2026-03-12	2026-03-10
8-K	2026-03-02	—
8-K	2026-01-05	—
8-K	2025-11-07	—
10-Q	2025-11-07	2025-09-30
8-K	2025-09-10	—
8-K	2025-08-22	2025-08-18
10-Q	2025-08-11	2025-06-30
8-K	2025-08-11	2025-08-05
8-K	2025-06-06	2025-06-04
8-K	2025-05-23	2025-05-22
8-K	2025-05-22	—
10-Q	2025-05-09	2025-03-31
8-K	2025-05-09	—
8-K	2025-04-28	—
DEF 14A	2025-04-21	2025-06-04
8-K	2025-03-17	—
10-K	2025-03-17	2024-12-31
8-K	2025-02-18	2025-02-14
8-K	2025-01-06	2024-12-31
8-K	2024-11-27	—
10-Q	2024-11-13	2024-09-30
8-K	2024-11-13	—
8-K	2024-08-13	—
10-Q	2024-08-13	2024-06-30
8-K	2024-08-08	2024-08-06
8-K	2024-07-05	2024-06-28
8-K	2024-06-17	2024-06-12
8-K	2024-05-30	—
10-Q	2024-05-13	2024-03-31
8-K	2024-05-09	—
8-K	2024-05-08	2024-05-07
DEF 14A	2024-04-29	2024-06-12
10-K	2024-03-27	2023-12-31

Showing 1–50 of 154 filings

Key facts CIK 1124105 CUSIP 403783103 13F (30d) 53 filings 53 filers Visit website Investor relations